Merganser Biotech
King Of Prussia, US · Delaware corporation · 4 known investors
Find your way into Merganser Biotech
Sign up to see every warm intro you have to Merganser Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Merganser Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BM
Brian MacDonaldExecutive
RS
Remy SukhijaExecutive
Board
JT

James TopperBoard directorManaging Partner at Frazier Life Sciences
MG
Markus GoebelBoard director
JB

Jeffrey BirdBoard directorManaging Director at Bluebird Ventures
CG
Colin GoddardBoard director
Investors · 4
Frazier Healthcare PartnersreportedSeattle · $50M – $400M
How we know: funding news · Not right? Tell us
Frazier Life SciencesinferredPalo Altovia James N. Topper · board
How we know: board seat on SEC Form D · Not right? Tell us
Novartis Venture FundreportedBasel · $5M – $25M
How we know: funding news · Not right? Tell us
Sutter Hill VenturesreportedPalo Alto · $100K – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$13.1M disclosed across 1 round · 2015
▶$13.1MraisedApr 2016 · 24 investors · BiotechnologyRule 506(b)
▶$13.1MraisedApr 2016 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James TopperDirector
- Colin GoddardDirector
- Markus GoebelDirector
- Brian MacDonaldExecutive Officer, Director
- Remy SukhijaExecutive Officer
- Jeffrey BirdDirector
- Offering amount
- $17.1M
- Amount sold
- $13.1M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Merganser Biotech's investors?
- Merganser Biotech's investors include Frazier Healthcare Partners, Frazier Life Sciences, Novartis Venture Fund, Sutter Hill Ventures.
- How much funding has Merganser Biotech raised?
- Merganser Biotech has disclosed $13.1M raised across 1 round.
- Where is Merganser Biotech headquartered?
- Merganser Biotech is headquartered in King Of Prussia, US.
